New hope for cancer wasting: nano drug aims to restore appetite and weight
NCT ID NCT07408505
First seen Feb 14, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study tests a new, easier-to-absorb version of megestrol acetate (a drug that stimulates appetite) in 56 people with advanced pancreatic cancer who are losing weight and appetite. The goal is to see if it helps them gain weight, feel better, and improve their quality of life during cancer treatment. Participants will be randomly assigned to receive either the nano-drug or a placebo alongside their standard cancer therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jinan, Shandong 0531
RECRUITINGJinan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.